CorMedix competitors

CorMedix's competitors include Alexion Pharmaceuticals, Syneos Health, ASIT Biotech and Veloxis Pharmaceuticals
Add company...
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Syneos Health
Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.
ASIT Biotech
ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.
Founding Date
Founding Date
2006
Founding Date
1992
Founding Date
2010
Founding Date
1997
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bedminster Township, US HQ
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Toronto, CA
see more
Locations
Raleigh, US HQ
Locations
Sint-Lambrechts-Woluwe, BE HQ
Locations
København, DK HQ
Employees
Employees
1456% increase
Employees
2,52519% decrease
Employees
6,800
Employees
20
Employees
53
Valuation ($)
Valuation ($)
60.2 m
Valuation ($)
27.8 b
Valuation ($)
5 b
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
793
Facebook likes
N/A
Facebook likes
7.3 k
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
620
Twitter followers
1.8 k
Twitter followers
12.1 k
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$329.3k (FY, 2017)
Revenue (est.)
$3.1b (FY, 2016)
Revenue (est.)
$1.6b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$115k (FY, 2017)
Cost of goods
$258m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$214.4k (FY, 2017)
Gross profit
$2.8b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($33m) (FY, 2017)
Net income
$399m (FY, 2016)
Net income
$112.6m (FY, 2016)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 11.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 60m
For sources of this data, please see the company profileDownload Excel

View company profiles

Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,525↓ 19% decrease

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
Syneos Health
HQ
Raleigh, US
Employees
6,800

Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.

View company
ASIT Biotech
HQ
Sint-Lambrechts-Woluwe, BE
Employees
20

ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.

View company
Veloxis Pharmaceuticals
HQ
København, DK
Employees
53

Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.

View company